Select a community
All Communities
Home > Community Treatment Reports > Ethinyl estradiol-levonorgestrel Treatment Report
What is Ethinyl estradiol-levonorgestrel?

This is an estrogen and progestin combination used for the prevention of pregnancy and for postcoital contraception. Off label it is used to treat abnormal uterine bleeding and pain associated with endometriosis.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
2 25%
None
6 75%

Most commonly reported side effects

Weight gain
2 25%
Depression
1 13%
  • Mild
  • Moderate
  • Severe

Dosages

  daily 1 other daily 25 mg daily 30 mcg-0.15 mg daily 30 mcg daily extended cycle 30 mcg-0.15 mg daily 20 mcg-100 mcg daily
  13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 8 Number of Patients: 8 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Ethinyl estradiol-levonorgestrel (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
2 33% Other: 33%
Did not seem to work
1 17% Did not seem to work: 17%
Expense
1 17% Expense: 17%
Doctor's advice
1 17% Doctor's advice: 17%
Course of treatment ended
1 17% Course of treatment ended: 17%

See all 6 patients who’ve stopped taking Ethinyl estradiol-levonorgestrel

Currently Taking Ethinyl estradiol-levonorgestrel

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
6
5
6
6

Stopped Taking Ethinyl estradiol-levonorgestrel

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
1
2
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
8 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
8 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 13%
< $25
3 38%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.